Clinical trial
An Exploratory Study of Low-dose Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer
NCT03129256 is registered in ClinicalTrials.gov with Changzhou Cancer Hospital of Soochow University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Study of Low-dose Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer
- Lead sponsor
- Changzhou Cancer Hospital of Soochow University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 1, 2016
- Completion date
- December 30, 2018
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer